|
HY-100815D-10mg
|
MedChemexpress LLC
|
(RS)-AMPA (monohydrate) [CAS 76463-67-7]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-100815D-5mg
|
MedChemexpress LLC
|
(RS)-AMPA (monohydrate) [CAS 76463-67-7]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-103450-10mg
|
MedChemexpress LLC
|
G36 [CAS 1392487-51-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-103450-100mg
|
MedChemexpress LLC
|
G36 [CAS 1392487-51-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-103450-25mg
|
MedChemexpress LLC
|
G36 [CAS 1392487-51-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-103450-5mg
|
MedChemexpress LLC
|
G36 [CAS 1392487-51-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-103450-50mg
|
MedChemexpress LLC
|
G36 [CAS 1392487-51-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-110028-10mg
|
MedChemexpress LLC
|
Leelamine (hydrochloride) [CAS 16496-99-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-110028-100mg
|
MedChemexpress LLC
|
Leelamine (hydrochloride) [CAS 16496-99-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-110028-5mg
|
MedChemexpress LLC
|
Leelamine (hydrochloride) [CAS 16496-99-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-110028-50mg
|
MedChemexpress LLC
|
Leelamine (hydrochloride) [CAS 16496-99-4]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-112543-10mg
|
MedChemexpress LLC
|
S119-8 [CAS 443639-96-1]
|
|
COVID-19-anti-virus
|
|
|
HY-112543-100mg
|
MedChemexpress LLC
|
S119-8 [CAS 443639-96-1]
|
|
COVID-19-anti-virus
|
|
|
HY-112543-25mg
|
MedChemexpress LLC
|
S119-8 [CAS 443639-96-1]
|
|
COVID-19-anti-virus
|
|
|
HY-112543-5mg
|
MedChemexpress LLC
|
S119-8 [CAS 443639-96-1]
|
|
COVID-19-anti-virus
|
|
|
HY-112543-50mg
|
MedChemexpress LLC
|
S119-8 [CAS 443639-96-1]
|
|
COVID-19-anti-virus
|
|
|
HY-112683-10mg
|
MedChemexpress LLC
|
V-9302 [CAS 1855871-76-9]
|
|
Cancer-programmed cell death
|
|
|
HY-112683-100mg
|
MedChemexpress LLC
|
V-9302 [CAS 1855871-76-9]
|
|
Cancer-programmed cell death
|
|
|
HY-112683-25mg
|
MedChemexpress LLC
|
V-9302 [CAS 1855871-76-9]
|
|
Cancer-programmed cell death
|
|
|
HY-112683-5mg
|
MedChemexpress LLC
|
V-9302 [CAS 1855871-76-9]
|
|
Cancer-programmed cell death
|
|
|
HY-112683-50mg
|
MedChemexpress LLC
|
V-9302 [CAS 1855871-76-9]
|
|
Cancer-programmed cell death
|
|
|
HY-112683A-10mg
|
MedChemexpress LLC
|
V-9302 (hydrochloride) [CAS 2416138-42-4]
|
|
Cancer-programmed cell death
|
|
|
HY-112683A-100mg
|
MedChemexpress LLC
|
V-9302 (hydrochloride) [CAS 2416138-42-4]
|
|
Cancer-programmed cell death
|
|
|
HY-112683A-25mg
|
MedChemexpress LLC
|
V-9302 (hydrochloride) [CAS 2416138-42-4]
|
|
Cancer-programmed cell death
|
|
|
HY-112683A-5mg
|
MedChemexpress LLC
|
V-9302 (hydrochloride) [CAS 2416138-42-4]
|
|
Cancer-programmed cell death
|
|
